SCHEMBL9538757

SCHEMBL9538757

CC(Cc1cccc2ccccc12)(OC(N)=O)C(=O)NCCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 4/20 0.50
PTPN1 P18031 1/20 0.48
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
MMP8 P22894 1/20 0.46
HPGD P15428 1/20 0.44
MCL1 Q07820 1/20 0.44
MTNR1B P49286 2/20 0.43
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
CCKBR P32239 1/20 0.43
TRPV1 Q8NER1 1/20 0.43
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
OPRK1 P41145 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
ALOX12 P18054 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9541636 0.85 MMP8 (0.49) MMP8RAB9ANPC1CCKBRPOLB
SCHEMBL9540255 0.84 MMP8 (0.44) KMT2AMMP8RAB9ANPC1CCKBR
SCHEMBL9538003 0.82 MMP8 (0.46) KMT2AMEN1MMP8RAB9ANPC1
SCHEMBL9539180 0.82 MMP8 (0.44) MTNR1AMMP8RAB9ANPC1POLB
SCHEMBL9538098 0.82 MMP8 (0.44) KMT2AMEN1MMP8MTNR1BRAB9A
SCHEMBL8486077 0.82 CCKBR (0.61) KMT2AMEN1CCKBRMAPTALDH1A1
SCHEMBL9541051 0.80 MMP8 (0.44) KMT2AMEN1MMP8RAB9ANPC1
SCHEMBL9539323 0.80 MMP8 (0.51) MMP8RAB9ANPC1POLBMAPT
SCHEMBL9699615 0.80 CCKBR (0.56) MTNR1APTPN1KMT2AMEN1MMP8
SCHEMBL9540074 0.78 RAB9A (0.51) KMT2AMEN1MMP8RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993003721-A1 CHOLECYSTOKININ ANTAGONISTS USEFUL FOR TREATING DEPRESSION WARNER-LAMBERT COMPANY (US) 1993-03-04 WO disclosed